Literature DB >> 18384984

Stability of proteins encapsulated in injectable and biodegradable poly(lactide-co-glycolide)-glucose millicylinders.

Jichao Kang1, Oliver Lambert, Michael Ausborn, Steven P Schwendeman.   

Abstract

PURPOSE: To characterize protein stability in poly(lactide-co-glycolide) 50/50-glucose star (PLGA-Glu) injectable millicylinders and to compare results with linear PLGA 50/50.
METHODS: Bovine serum albumin (BSA), a model protein, was encapsulated in PLGA-Glu and linear PLGA millicylinders by solvent-extrusion and incubated under physiological conditions. Important system properties were characterized, including: polymer molecular weight distribution, soluble acidic residues, polymer morphology, polymer water uptake, microclimate pH, protein content and release, and protein aggregation. The polymer microclimate late in the release incubation was simulated and protein recovery was analyzed by UV280, size exclusion chromatography, amino acid analysis, and a modified Bradford assay.
RESULTS: PLGA-Glu contained higher levels of low molecular weight oligomers, more rapidly biodegraded, and exhibited a lower microclimate pH than the linear 50/50 PLGA, which is the most acidic type in the PLGA family. BSA, when encapsulated in PLGA-Glu millicylinders, underwent extensive noncovalent insoluble aggregation over 2 weeks in vitro release, which was almost completely inhibited upon co-encapsulation of Mg(OH)2. However, by 5 weeks release for base-containing formulations, although insoluble aggregation was still suppressed, the soluble fraction of protein in the polymer was unrecoverable by the modified Bradford assay. Polymer microclimate simulations with extensive protein analysis strongly suggested that the low recovery was mostly caused by base-catalyzed hydrolysis of the oligomeric fraction of BSA.
CONCLUSIONS: In PLGA-Glu, the acidic microclimate was similarly responsible for insoluble aggregation of encapsulated BSA. BSA aggregation was inhibited in millicylinders by co-incorporation into the polymer an insoluble base, but over a shorter release interval than linear PLGA likely because of a more acidic microclimate in the star polymer.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18384984      PMCID: PMC4269258          DOI: 10.1016/j.ijpharm.2008.02.004

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  30 in total

1.  Pore closing and opening in biodegradable polymers and their effect on the controlled release of proteins.

Authors:  Jichao Kang; Steven P Schwendeman
Journal:  Mol Pharm       Date:  2007 Jan-Feb       Impact factor: 4.939

2.  Stability of poly(D,L-lactide-co-glycolide) and leuprolide acetate in in-situ forming drug delivery systems.

Authors:  W Y Dong; M Körber; V López Esguerra; R Bodmeier
Journal:  J Control Release       Date:  2006-07-20       Impact factor: 9.776

3.  Injectable polymer microspheres enhance immunogenicity of a contraceptive peptide vaccine.

Authors:  Chengji Cui; Vernon C Stevens; Steven P Schwendeman
Journal:  Vaccine       Date:  2006-08-17       Impact factor: 3.641

4.  Prediction of microclimate pH in poly(lactic-co-glycolic acid) films.

Authors:  Amy G Ding; Anna Shenderova; Steven P Schwendeman
Journal:  J Am Chem Soc       Date:  2006-04-26       Impact factor: 15.419

5.  Stabilization of proteins encapsulated in cylindrical poly(lactide-co-glycolide) implants: mechanism of stabilization by basic additives.

Authors:  G Zhu; S P Schwendeman
Journal:  Pharm Res       Date:  2000-03       Impact factor: 4.200

6.  One-month release injectable microcapsules of a luteinizing hormone-releasing hormone agonist (leuprolide acetate) for treating experimental endometriosis in rats.

Authors:  H Okada; T Heya; Y Ogawa; T Shimamoto
Journal:  J Pharmacol Exp Ther       Date:  1988-02       Impact factor: 4.030

7.  Heparin immobilized porous PLGA microspheres for angiogenic growth factor delivery.

Authors:  Hyun Jung Chung; Hong Kee Kim; Jun Jin Yoon; Tae Gwan Park
Journal:  Pharm Res       Date:  2006-08       Impact factor: 4.200

8.  The reactions of phenylglyoxal and related reagents with amino acids.

Authors:  K Takahashi
Journal:  J Biochem       Date:  1977-02       Impact factor: 3.387

9.  Factors affecting the degradation rate of poly(lactide-co-glycolide) microspheres in vivo and in vitro.

Authors:  M A Tracy; K L Ward; L Firouzabadian; Y Wang; N Dong; R Qian; Y Zhang
Journal:  Biomaterials       Date:  1999-06       Impact factor: 12.479

Review 10.  Solid-phase aggregation of proteins under pharmaceutically relevant conditions.

Authors:  H R Costantino; R Langer; A M Klibanov
Journal:  J Pharm Sci       Date:  1994-12       Impact factor: 3.534

View more
  13 in total

Review 1.  Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release.

Authors:  Nazila Kamaly; Basit Yameen; Jun Wu; Omid C Farokhzad
Journal:  Chem Rev       Date:  2016-02-08       Impact factor: 60.622

2.  Mapping microclimate pH distribution inside protein-encapsulated PLGA microspheres using confocal laser scanning microscopy.

Authors:  Yajun Liu; Steven P Schwendeman
Journal:  Mol Pharm       Date:  2012-04-23       Impact factor: 4.939

3.  The microclimate pH in poly(D,L-lactide-co-hydroxymethyl glycolide) microspheres during biodegradation.

Authors:  Yajun Liu; Amir H Ghassemi; Wim E Hennink; Steven P Schwendeman
Journal:  Biomaterials       Date:  2012-07-21       Impact factor: 12.479

4.  Sustained-release delivery of octreotide from biodegradable polymeric microspheres.

Authors:  Yun-Seok Rhee; MinJi Sohn; Byung H Woo; B C Thanoo; Patrick P DeLuca; Heidi M Mansour
Journal:  AAPS PharmSciTech       Date:  2011-09-27       Impact factor: 3.246

5.  Targeted Interleukin-10 Nanotherapeutics Developed with a Microfluidic Chip Enhance Resolution of Inflammation in Advanced Atherosclerosis.

Authors:  Nazila Kamaly; Gabrielle Fredman; Jhalique Jane R Fojas; Manikandan Subramanian; Won Ii Choi; Katherine Zepeda; Cristian Vilos; Mikyung Yu; Suresh Gadde; Jun Wu; Jaclyn Milton; Renata Carvalho Leitao; Livia Rosa Fernandes; Moaraj Hasan; Huayi Gao; Vance Nguyen; Jordan Harris; Ira Tabas; Omid C Farokhzad
Journal:  ACS Nano       Date:  2016-04-28       Impact factor: 15.881

6.  Oriented Nanofibrous Polymer Scaffolds Containing Protein-Loaded Porous Silicon Generated by Spray Nebulization.

Authors:  Jonathan M Zuidema; Tushar Kumeria; Dokyoung Kim; Jinyoung Kang; Joanna Wang; Geoffrey Hollett; Xuan Zhang; David S Roberts; Nicole Chan; Cari Dowling; Elena Blanco-Suarez; Nicola J Allen; Mark H Tuszynski; Michael J Sailor
Journal:  Adv Mater       Date:  2018-01-24       Impact factor: 30.849

Review 7.  How does the pathophysiological context influence delivery of bone growth factors?

Authors:  Xiaohua Yu; Darilis Suárez-González; Andrew S Khalil; William L Murphy
Journal:  Adv Drug Deliv Rev       Date:  2014-10-17       Impact factor: 15.470

8.  Minimizing acylation of peptides in PLGA microspheres.

Authors:  Ying Zhang; Steven P Schwendeman
Journal:  J Control Release       Date:  2012-04-21       Impact factor: 9.776

9.  Pluronic-modified superoxide dismutase 1 attenuates angiotensin II-induced increase in intracellular superoxide in neurons.

Authors:  Xiang Yi; Matthew C Zimmerman; Ruifang Yang; Jing Tong; Serguei Vinogradov; Alexander V Kabanov
Journal:  Free Radic Biol Med       Date:  2010-05-20       Impact factor: 7.376

10.  Cell-Demanded VEGF Release via Nanocapsules Elicits Different Receptor Activation Dynamics and Enhanced Angiogenesis.

Authors:  Suwei Zhu; Tatiana Segura
Journal:  Ann Biomed Eng       Date:  2016-03-03       Impact factor: 3.934

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.